Tresiba significantly lowers hypo rates
New results from two Phase 3b trials have shown people with type 1 and type 2 diabetes treated with Tresiba® (insulin degludec) experienced significantly lower rates of several types of ...
New results from two Phase 3b trials have shown people with type 1 and type 2 diabetes treated with Tresiba® (insulin degludec) experienced significantly lower rates of several types of ...
Diabetes healthcare professionals in America are being urged not to use the word “diabetic” by a leading national body. The new guidelines have been issued in the 2016 Standards of ...
People who have chronic heart failure (CHF) and type 2 diabetes should have their diabetes treated less aggressively, according to new research. A study, conducted by Dundee University looked at ...
Two professors from Leicester have been named in a list of the top ten diabetes experts in the world. Professors Kamlesh Khunti and Melanie Davies were recognised among the global elite in their ...